Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.08 USD
Change Today 0.00 / 0.00%
Volume 0.0
ORXE On Other Exchanges
As of 8:10 PM 11/19/15 All times are local (Market data is delayed by at least 15 minutes).

ore holdings inc (ORXE) Snapshot

Previous Close
Day High
Day Low
52 Week High
12/17/14 - $0.26
52 Week Low
08/27/15 - $0.07
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ORE HOLDINGS INC (ORXE)

Related News

No related news articles were found.

ore holdings inc (ORXE) Related Businessweek News

No Related Businessweek News Found

ore holdings inc (ORXE) Details

Ore Holdings, Inc. focuses on developing and monetizing pharmaceutical assets, including clinical-stage compounds in-licensed from pharmaceutical companies. Its drug candidate portfolio includes ORE1001, an orally-administered small molecule drug for treating inflammatory bowel disease and other gastrointestinal indications; ORE10002, a small molecule serotonergic agent for inflammatory and autoimmune diseases; tiapamil, a small molecule L-type calcium channel antagonist to treat cardiovascular disease, various cognitive disorders, and gastrointestinal indications; and romazarit, a small molecule PPAR√° agonist for autoimmune, metabolic, inflammatory, and gastrointestinal diseases. The company was formerly known as Ore Pharmaceutical Holdings Inc. and changed its name to Ore Holdings, Inc. in June 2011. Ore Holdings, Inc. was founded in 1994 and is based in Cambridge, Massachusetts.

ore holdings inc (ORXE) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ORXE:US $0.08 USD 0.00

ORXE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Foundation Medicine Inc $17.36 USD +1.03
Laboratory Corp of America Holdings $122.07 USD +0.25
Quest Diagnostics Inc $68.76 USD +0.23
View Industry Companies

Industry Analysis


Industry Average

Valuation ORXE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ORE HOLDINGS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at